Novalis Biotech

Ottergemsesteenweg Zuid 808 Bus B511

9000 Gent

BE

Novalis Biotech

Foundation date

21/08/2017

Sector

#Investor

Subsector

Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.

Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.

Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.

As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.

Upcoming events

Latest news

  • Mithra reaches milestone in estetrol skin study

    Tuesday April 9th 2024

  • Stool transplant shows promise for Parkinson's disease

    Thursday April 4th 2024

  • Strong data from Sequana Medical's DSRĀ® proof-of-concept studies in heart failure published in European Journal of Heart Failure

    Wednesday April 3rd 2024